English
  1. Home
  2. Stocks
  3. Pel Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Piramal Enterprises Share Price Piramal Enterprises

    Mid Cap
    ₹826.8
    -20.6 (-2.43%)
    14 May, 2024 01:29 BSE: 500302 NSE: PELISIN: INE140A01024

    Start SIP in Piramal Enterprises

    Start SIP

    Piramal Enterprises Performance

    Day Range

    • Low 807
    • High 852
    ₹ 826

    52 Week Range

    • Low 721
    • High 1,140
    ₹ 826
    • Open Price851
    • Previous Close847
    • Volume2354683

    Piramal Enterprises Share Price

    • Over 1 Month -3.75%
    • Over 3 Month -3.81%
    • Over 6 Month -13.25%
    • Over 1 Year +13.88%

    Piramal Enterprises Key Statistics

    P/E Ratio -11
    PEG Ratio 0.1
    Market Cap Cr 18,575
    Price to Book Ratio 0.6
    EPS 35.4
    Dividend 3.7
    Relative Strength Index 39.81
    Money Flow Index 58.65
    MACD Signal 9.09
    Average True Range 32.54

    Piramal Enterprises F&O

    Piramal Enterprises Futures Piramal Enterprises Option Chain
    Piramal Enterprises Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 5466164861,194181
    Operating Expenses Qtr Cr 21739661627031
    Operating Profit Qtr Cr 784367153925150
    Depreciation Qtr Cr 6652322
    Interest Qtr Cr 205188151201167
    Tax Qtr Cr 285-378415246
    Net Profit Qtr Cr 954-1,0603577-57
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,8254,837
    Operating Expenses Annual Cr 1,5061,704
    Operating Profit Annual in Cr 2,2293,082
    Depreciation Cr 67323
    Interest Annual Cr 745712
    Tax Annual Cr 63-22
    Net Profit Annual Cr 47414,333
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 917
    Cash from Investing Activity Annual Cr -37
    Cash from Financing Annual Activity Cr -604
    Net Cash Flow Annual Cr 276
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 024,034
    Fixed Assets Annual Cr 01,368
    Total Non Current Assets Annual Cr 3362,573
    Total Current Assets Annual Cr 1,35930,531
    Total Assets Annual Cr 1,69633,104
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1,0071,007
    ROE Annual % 6060
    ROCE Annual % 1111
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 6565
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,5962,4522,0092,8042,132
    Operating Expenses Qtr Cr 2,3031,1231,3202,3593,820
    Operating Profit Qtr Cr -3671,2051,1181,713813
    Depreciation Qtr Cr 71241383741
    Interest Qtr Cr 1,1671,1031,0391,035991
    Tax Qtr Cr -821-958111732
    Net Profit Qtr Cr 137-2,37848509-196
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 9,087
    Operating Expenses Annual Cr 7,434
    Operating Profit Annual in Cr 1,500
    Depreciation Cr 123
    Interest Annual Cr 3,994
    Tax Annual Cr -3,978
    Net Profit Annual Cr 9,969
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 1,359
    Cash from Investing Activity Annual Cr -351
    Cash from Financing Annual Activity Cr -3,325
    Net Cash Flow Annual Cr -2,316
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 31,059
    Fixed Assets Annual Cr 2,997
    Total Non Current Assets Annual Cr 5,571
    Total Current Assets Annual Cr 78,181
    Total Assets Annual Cr 83,752
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1,301
    ROE Annual % 32
    ROCE Annual % 2
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 19
    Sign Up to Know More
    Invest in Piramal Enterprises

    Piramal Enterprises Technicals

    EMA & SMA

    Current Price
    ₹826.8
    -20.6 (-2.43%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹881.61
    • 50 Day
    • ₹881.65
    • 100 Day
    • ₹894.88
    • 200 Day
    • ₹921.94
    • 20 Day
    • ₹882.08
    • 50 Day
    • ₹874.42
    • 100 Day
    • ₹892.33
    • 200 Day
    • ₹951.65

    Piramal Enterprises Resistance and Support

    PIVOT
    ₹828.47
    Resistance
    First Resistance 850.28
    Second Resistance 873.77
    Third Resistance 895.58
    RSI 39.81
    MFI 58.65
    MACD Single Line 9.09
    MACD -0.60
    Support
    First Resistance 804.98
    Second Resistance 783.17
    Third Resistance 759.68

    Piramal Enterprises Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,465,490 64,053,430 25.98
    Week 2,594,212 91,653,496 35.33
    1 Month 1,806,441 73,504,080 40.69
    6 Month 1,561,001 64,203,964 41.13

    Piramal Enterprises Result Highlights

    Piramal Enterprises Synopsis

    NSE-Finance-Commercial Loans

    Piramal Enterprises is involved in the business activities of Other financial service activities, except insurance and pension funding activities. Company’s Total Operating Revenue is Rs. 4785.22 Cr. and Equity Capital is Rs. 47.73 Cr. for the Year ended 31/03/2023. Piramal Enterprises Ltd. is a Public Limited Listed company incorporated on 26/04/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1947PLC005719 and registration number is 005719.
    Market Cap 18,575
    Sales 3,778
    Shares in Float 12.13
    No of funds 283
    Yield 3.35
    Book Value 0.81
    U/D Vol ratio 1
    LTDebt / Equity 18
    Alpha -0.1
    Beta 1.79

    Piramal Enterprises

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 46.19%46.19%46.19%43.48%
    Mutual Funds 6.68%6.55%5.83%5.85%
    Insurance Companies 5.45%5.25%5.12%5.96%
    Foreign Portfolio Investors 16.97%17.19%19.69%26.04%
    Financial Institutions/ Banks 0.01%
    Individual Investors 16.48%16.51%15.13%13.34%
    Others 8.23%8.31%8.04%5.32%

    Piramal Enterprises Management

    Name Designation
    Mr. Ajay G Piramal Chairman
    Dr.(Mrs.) Swati A Piramal Vice Chairperson
    Ms. Nandini Piramal Executive Director
    Mr. Puneet Dalmia Independent Director
    Mr. Anand Piramal Non Executive Director
    Mr. Vijay Shah Non Executive Director
    Mr. Kunal Bahl Independent Director
    Mr. Khushru Jijina Executive Director
    Ms. Anjali Bansal Independent Director
    Mr. S Ramadorai Independent Director
    Mr. Shikha Sharma Independent Director
    Mr. N Vaghul Independent Director
    Mr. Suhail Nathani Independent Director
    Mr. Anita George Independent Director
    Mr. Rajiv Mehrishi Independent Director
    Mr. Gautam Bhailal Doshi Ind. Non-Executive Director

    Piramal Enterprises Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Piramal Enterprises Corporate Action

    Date Purpose Remarks
    2024-05-08 Audited Results & Final Dividend
    2024-01-29 Quarterly Results
    2023-11-09 Quarterly Results
    2023-07-28 Quarterly Results & Buy Back
    2023-05-05 Audited Results & Final Dividend
    Date Purpose Remarks
    2023-06-16 FINAL Rs.31.00 per share(1550%)Final Dividend
    2022-07-15 FINAL Rs.33.00 per share(1650%)Final Dividend
    2021-07-07 FINAL Rs.33.00 per share(1650%)Final Dividend

    Piramal Enterprises MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 83,549
    Parag Parikh Flexi Cap Regular Growth 60,559
    Kotak Equity Arbitrage Fund Growth 43,515
    SBI Arbitrage Opportunities Fund Regular Growth 29,009
    Nippon India Growth Fund - Growth 26,822

    About Piramal Enterprises

    Piramal Enterprises Limited is an Indian multinational pharmaceutical and financial services company based in Mumbai, Maharashtra. Founded by Ajay Piramal (who is also the Chairman), the company operates in the pharmaceuticals, financial services and real estate sector.

    He founded the company in 1984 after he acquired a small-scale manufacturing unit from his father. Today, Piramal has more than 50 offices across 30 countries and employs over 10,000 people worldwide. With a presence in 100+ countries through its subsidiaries or associate companies. Piramal has been ranked among Forbes Asia’s 200 Best Under A Billion in 2019.

    Business Verticals

    PEL's Global Pharma division has a strong product portfolio of niche differentiated branded generics that are difficult to manufacture, sell, or distribute. Through its worldwide network of facilities, PEL's Contract Development and Manufacturing Organisation (CDMO) services segment provide end-to-end solutions across the drug life cycle. 

    The Indian consumer products division of PEL serves India’s self-care market. PEL's OTC portfolio includes 21 major pharmaceutical and personal care brands in diverse product categories such as Vitamins & Nutrition, Dermatological & Antacids, Analgesics, and Baby Care. PEL's Healthcare Insights & Analytics division is the world's leading provider of healthcare analytics data, insight products and services to the world's leading pharma, biotech and medical technology companies, allowing them to make informed business decisions.

    PEL's financial services include wholesale lending, housing finance, and alternative asset management. Piramal Capital & Housing Finance Ltd, PEL's wholly-owned subsidiary, is registered as a housing finance company with National Housing Bank (NHB) and is involved in a variety of financial services businesses. It offers wholesale and retail funding opportunities across industries.

    Company History

    Piramal Enterprises was founded as Indian Schering Limited on April 26, 1947, by British Schering Ltd. With effect from September 27, 1979, the company's name was changed from Indian Schering Ltd to Nicholas Laboratories India Ltd. Gujarat Glass Ltd (GGL) was acquired with the company on April 1, 1990. The new formulation plant in Pithampur, Madhya Pradesh, was inaugurated in 1991. After a year, in 1992, the company established a second formulation plant in Pithampur, Madhya Pradesh, with cutting-edge manufacturing facilities. The company's name changed from 'Nicholas Laboratories Ltd' to 'Nicholas Piramal India Ltd' on December 2, 1992.
     

    Milestones

    1988
    Entered the pharmaceutical industry with the purchase of Nicholas Laboratories.
    A series of mergers and acquisitions, joint ventures and alliances, and organic initiatives.

    2010
    Over two decades, they built a leading Indian pharmaceutical company.
    The Domestic Formulations business was sold to Abbott in 2010 for USD 3.8 billion. Diagnostic Services were sold to Super Religare Laboratories.

    From 2020 onwards
    Multiple capital raise initiatives helped to strengthen the balance sheet.
    Through the sale of DRG and the exit of Shriram Transport, the organization structure was simplified.
    Subsidized the pharmaceutical businesses and raised new capital from Carlyle Transforming Financial Services with the DHFL acquisition to deliver long-term growth and profitability.
     

    Piramal Enterprises FAQs

    What is Share Price of Piramal Enterprises ?

    Piramal Enterprises share price is ₹826 As on 14 May, 2024 | 01:15

    What is the Market Cap of Piramal Enterprises ?

    The Market Cap of Piramal Enterprises is ₹18575.2 Cr As on 14 May, 2024 | 01:15

    What is the P/E ratio of Piramal Enterprises ?

    The P/E ratio of Piramal Enterprises is -11 As on 14 May, 2024 | 01:15

    What is the PB ratio of Piramal Enterprises ?

    The PB ratio of Piramal Enterprises is 0.6 As on 14 May, 2024 | 01:15

    What were the company's most recent reported sales and net income?

    Piramal Enterprises Ltd recorded net sales of INR 13993 crores in the year ending March 2022. 

    What is the future of the company's shares?

    Piramal Enterprises Ltd stock may be a good buy according to market analysts considering meaningful inroads into Retail led by mortgages and small-term loans via digital alliance.

    How to buy shares of Piramal Enterprises Ltd.?

    The company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.